Who are Sera Prognostics, Inc.'s major customers?

Sera Prognostics, Inc. (SERA) key customers include: Elevance Health, Inc., Elevance Health, Inc., EMERGING-GROWTH-COMPANY. View the full customer network at chainsifter.com/chain/SERA.

What sector is Sera Prognostics, Inc. in?

Sera Prognostics, Inc. (SERA) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Sera Prognostics, Inc. (SERA): 5 Verified Supply Chain Relationships

0Suppliers

3Customers

2Debt Items

8Related Chains

Source-Backed Evidence Depth

Sera Prognostics, Inc. (SERA) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

6Total relationships

2Distinct source URLs

5High confidence

0.860Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Sera Prognostics, Inc. Suppliers

No suppliers on recordSera Prognostics, Inc. does not appear to disclose named supplier relationships in its verified regulatory filings, or upstream suppliers have not yet been identified. Our system processes new filings continuously.

Sera Prognostics, Inc. Customers

Ticker	Name	Confidence	Evidence
ELV	Elevance Health, Inc.	92%	We expect that a significant portion of our revenue and cash flows in the near future will be related to sales to a limited number of customers, including Elevance Health, the loss of any of which co…
ELV	Elevance Health, Inc.	92%	Reciprocal relationship from ELV graph: Reciprocal relationship from SERA graph: We expect that a significant portion of our revenue and cash flows in the near future will be related to sales to a li…
EMERGING-GROWTH-COMPANY	EMERGING-GROWTH-COMPANY	62%	aboratory operations costs. The $0.2 million decrease in research and bioinformatics costs was primarily due to a $0.1 million decrease in consulting costs and a $0.1 million decrease in stock-based …

Sera Prognostics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
SERA-DEBT-12471	Warrants outstanding: 81543	90%	xbrl warrant detail from xbrl 2021-12-31.
SERA-DEBT	Debt stack $2.5M	90%	Market cache reports total debt of $2.5M.

Sera Prognostics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Sera Prognostics, Inc..

Sera Prognostics, Inc. Ownership

Holder	Name	Confidence	Evidence
SERA-OWNER-BAKER-BROS-ADVISORS-LP	BAKER BROS. ADVISORS LP	90%	13F overlay lists BAKER BROS. ADVISORS LP as top holder; 58 tracked holders.

Sera Prognostics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
HNGE	Hinge Health, Inc.	100.00	2
CVS	CVS Health Corporation	100.00	2
ELV	Elevance Health, Inc.	100.00	1	['customer']
RNLXY	Renalytix Plc	50.00	2
AMWL	American Well Corporation	50.00	2
LFST	LifeStance Health Group, Inc.	50.00	2
GOCO	GoHealth, Inc.	50.00	2
SWK	Stanley Black & Decker, Inc.	50.00	2

Sera Prognostics, Inc. Supply Chain